Opinion: Bailout US Cancer Care Opinion: Bailout US Cancer Care
The authors argue that'ensuring the short-term solvency of independent practices is critical to preserving patients'access to cancer care. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 24, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pandemic Epiphany: Medicine Isn't Worth It Pandemic Epiphany: Medicine Isn't Worth It
The pandemic has many doctors reconsidering whether a life in medicine is worth all the missed soccer games and family dinners.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Lower BP and Better Tumor Control With Drug Combo? Lower BP and Better Tumor Control With Drug Combo?
Angiotensin II receptor blockers but not angiotensin converting enzyme inhibitors were associated with better responses and survival for patients receiving immune checkpoint inhibitors for cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

pCR in HER2+ Breast Cancer Predicts Long-Term Survival pCR in HER2+ Breast Cancer Predicts Long-Term Survival
A pathologic complete response to targeted therapy in HER2-positive breast cancer portends good long-term outcomes and may be a marker of cure, according to the final results of a phase 3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 21, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Gene Signature May Be Similarly Prognostic in ILC and IDC Gene Signature May Be Similarly Prognostic in ILC and IDC
The MammaPrint 70-gene signature has similar prognostic performance in women with early-stage invasive lobular carcinoma and invasive ductal carcinoma (IDC), according to an exploratory analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 20, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Popularity of Virtual Conferences May Mean a Permanent Shift Popularity of Virtual Conferences May Mean a Permanent Shift
Turning in-person medical meetings into online events in the wake of the pandemic levelled the playing field for people who haven't traditionally had access to such meetings.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 20, 2020 Category: Cancer & Oncology Tags: Business of Medicine News Source Type: news

Osimertinib as Adjuvant Therapy in EGFR-Mutant Lung Cancer Osimertinib as Adjuvant Therapy in EGFR-Mutant Lung Cancer
Dr Mark Kris discusses how recent data presented at ESMO continue to support osimertinib as an important drug in the adjuvant setting for patients with completely resected EGFR-mutant lung cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 17, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Are Oncologists Ready to Confront a Second Wave of COVID-19? Are Oncologists Ready to Confront a Second Wave of COVID-19?
As COVID-19 cases continue to increase or increase again worldwide, Medscape reached out to oncologists in different countries to hear how they are preparing and what they learned from the first wave.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 16, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EMA OKs First CAR T-Cell Therapy for Mantle Cell Lymphoma EMA OKs First CAR T-Cell Therapy for Mantle Cell Lymphoma
Brexucabtagene autoleucel (Tecartus) is a new cell therapy product and the only one with an indication for this particular hematological malignancy.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 16, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Oncology Is Not Immune From Online'Confirmation Bias'Oncology Is Not Immune From Online'Confirmation Bias '
Far too often, online discussions among oncologists cross the line into specious and even dangerous territory.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 15, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Viagra to Fight Cancer? (Plus an'Immensely Embarrassing' Story) Viagra to Fight Cancer? (Plus an'Immensely Embarrassing' Story)
Dr David Kerr discusses recent data on phosphodiesterase-5 inhibitor use in patients with colorectal cancer, and his own experience with Viagra.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 15, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Surveillance After CRC Resection Does Not Improve Survival Surveillance After CRC Resection Does Not Improve Survival
Surveillance with carcinoembryonic antigen testing and CT scans after colorectal cancer resection did not improve survival when compared with standard abdominal ultrasound and chest x-ray monitoring.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 14, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Chemoradiation Boosts Glioblastoma Survival in Real-World Setting Chemoradiation Boosts Glioblastoma Survival in Real-World Setting
Adding systemic chemotherapy with temozolomide to radiotherapy offers a significant survival benefit over radiotherapy alone, study findings indicate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 13, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Researchers Cross Over to COVID-19 Clinical Trials Cancer Researchers Cross Over to COVID-19 Clinical Trials
Cancer researchers are contributing to the development and repurposing of drugs for the treatment of COVID-19, particularly for cytokine storm.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 13, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Profound Human Toll' in Excess Deaths From COVID-19 Reported'Profound Human Toll' in Excess Deaths From COVID-19 Reported
Increased deaths due to heart disease and Alzheimer's disease or dementia also increased as a result of the COVID-19 pandemic, research shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 12, 2020 Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news

Delayed Cancer Screening Could Cause Increase in Deaths Delayed Cancer Screening Could Cause Increase in Deaths
When compared with a delay of less than 3 months, the longer delay seen this year may result in an 11.9% increase in death rates.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 12, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Malignant' Takes a Critical Look at Cancer Policy'Malignant' Takes a Critical Look at Cancer Policy
A family physician with an interest in cancer medicine reviews Dr Vinay Prasad's latest book, Malignant.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 12, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Clinical Factors and Treatment Tied to COVID-19 Mortality Clinical Factors and Treatment Tied to COVID-19 Mortality
Mortality in patients with COVID-19 and cancer is associated with general clinical and demographic factors, cancer-specific factors, cancer treatment variables, and laboratory parameters.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 9, 2020 Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news

David Kerr on ESMO's Most Important Colorectal Cancer Trials David Kerr on ESMO's Most Important Colorectal Cancer Trials
Dr David Kerr discusses four studies that caught his eye at this year's virtual ESMO meeting.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 9, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Meta-Analysis: Acalabrutinib Bests Other Frontline CLL Therapies Meta-Analysis: Acalabrutinib Bests Other Frontline CLL Therapies
Acalabrutinib, alone or in combination with obinutuzumab, showed favorable progression-free survival and overall survival compared with other frontline therapies for chronic lymphocytic leukemia.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 9, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Continue Cancer Care With Caution' Despite Pandemic'Continue Cancer Care With Caution' Despite Pandemic
New data show morbidity and mortality rates from COVID-19 are similar for individuals with or without cancer, suggesting that cancer care can be continued despite the pandemic.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Restarting Breast Cancer Screening After Covid-19 Disruption Restarting Breast Cancer Screening After Covid-19 Disruption
Restarting breast cancer screening programs after the COVID-19 disruption will be challenging given a trade-off between minimizing excess mortality and strain on programs, according to a modeling study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

No Increase in Suicide Risk Among Childhood Cancer Survivors: Study No Increase in Suicide Risk Among Childhood Cancer Survivors: Study
In contrast with previous studies, a new analysis finds a lower risk of suicidal behaviors and suicide-related death among survivors compared with controls.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Contrary' to Wide Belief, Abscopal Effect Is Rare in Cancer'Contrary' to Wide Belief, Abscopal Effect Is Rare in Cancer
The abscopal effect, whereby tumors are reduced or eliminated even though they are situated outside the radiation field, was first described in the 1950s. But is it largely the result of chance?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

7 Things to Know About New Lymphoma Drug Tafasitamab 7 Things to Know About New Lymphoma Drug Tafasitamab
Lymphoma specialist Ann LaCasce, MD, discusses tafasitamab-cxix, the recently approved treatment for patients with relapsed/refractory disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 5, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

A Uniquely Patient-Focused Take on Treating AML in Older Adults A Uniquely Patient-Focused Take on Treating AML in Older Adults
Dr Mikkael Sekeres discusses how the recent ASH guidelines, on which he is a coauthor, are meant to guide the difficult decisions that follow a new diagnosis of AML in older patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 5, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Combo Therapy for First-Line Mesothelioma Treatment FDA OKs Combo Therapy for First-Line Mesothelioma Treatment
Combination nivolumab and ipilimumab has now been approved as first-line treatment in mesothelioma and possibly a new standard of care.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 3, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Orthopedic Problems in Children Can Be the First Sign of ALL Orthopedic Problems in Children Can Be the First Sign of ALL
The diagnosis of acute lymphoblastic leukemia (ALL) can be delayed because of vague presentation and normal hematological results.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 2, 2020 Category: Cancer & Oncology Tags: Pediatrics News Source Type: news

UK Physicians Call for Fresh Debate on Medically Assisted Dying UK Physicians Call for Fresh Debate on Medically Assisted Dying
Three physicians, one of whom has incurable cancer, argue that it is time for a fresh debate on medically assisted dying in the UK, where the practice is illegal.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 2, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

HPV Vaccine Shown to Substantially Reduce Cervical Cancer Risk HPV Vaccine Shown to Substantially Reduce Cervical Cancer Risk
A review from Sweden of more than 1 million girls/women vaccinated in 2006 – 2017 shows a substantial reduction in the risk for invasive cervical cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 1, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

High TMB Predicts Response to Pembrolizumab High TMB Predicts Response to Pembrolizumab
Details of the data that led to FDA approval of tumor mutation burden (TMB) as a biomarker for pembrolizumab use in advanced cancers have now been published.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 30, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Physicians Misjudge a Terminal Patient's Life Span: Is It Fraud? Physicians Misjudge a Terminal Patient's Life Span: Is It Fraud?
Physicians can recommend that patients receive hospice care when they have less than 6 months to live; but what if their prognosis is not accurate? Are doctors at risk?Medscape Business of Medicine (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 30, 2020 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

CRC Risk: Raised by Meat/Alcohol, Lowered by Aspirin/NSAIDs CRC Risk: Raised by Meat/Alcohol, Lowered by Aspirin/NSAIDs
A new meta-analysis has largely confirmed what is already known about lifestyle factors that increase or lower the risk for colorectal cancer (CRC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Disparities: One of the Most Pressing Public Health Issues Cancer Disparities: One of the Most Pressing Public Health Issues
"There is...a need for our nation's leaders to take on a much bigger role in confronting and combat-ing the structural and systemic racism that contributes to health disparities," says the AACR.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Divergent Findings With Paclitaxel and Nab-Paclitaxel in TNBC Divergent Findings With Paclitaxel and Nab-Paclitaxel in TNBC
Certain patients with triple-negative breast cancer (TNBC) may benefit when atezolizumab is combined with nab-paclitaxel but not with paclitaxel, a pair of phase 3 trials suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Long-Running' Conspiracy: Cancer Center's Ex-Top Doc Indicted'Long-Running' Conspiracy: Cancer Center's Ex-Top Doc Indicted
The former head of Florida Cancer Specialists has been indicted by a federal grand jury for conspiring to restrict cancer patients'choice of a treatment provider.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Predicting Complications of Cytoreductive Nephrectomy in mRCC Predicting Complications of Cytoreductive Nephrectomy in mRCC
Patients with higher intraoperative blood loss and those treated at lower-volume surgical centers had a greater risk of high-grade complications after undergoing CN for mRCC, according data analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 26, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Hepatocellular Carcinoma Shows Risk Factor Shift Hepatocellular Carcinoma Shows Risk Factor Shift
The most common form of liver cancer has seen a demographic shift, with incidence highest in the Hispanic population. The good news in HCC is that rates appear to be declining among young men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 25, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

US Health Department's Caputo Has Cancer, Spokesperson Says US Health Department's Caputo Has Cancer, Spokesperson Says
Michael Caputo, who is on leave from his role as spokesperson for the U.S. Department of Health and Human Services after accusing government scientists of sedition, has metastatic cancer, a state lawmaker said.Associated Press (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 25, 2020 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

What Do You Think of Virtual Medical Meetings? What Do You Think of Virtual Medical Meetings?
If you have participated in a virtual medical meeting this year, tell us about your experience.Medscape Reader Polls (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 25, 2020 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

For Immunotherapy in TNBC, Nab-paclitaxel Is a Must For Immunotherapy in TNBC, Nab-paclitaxel Is a Must
Why are results so different between IMpassion130 and IMpassion131? There is no clear answer, says Dr Kathy Miller.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 24, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Pembrolizumab Shows Activity in Select Rare Sarcomas Pembrolizumab Shows Activity in Select Rare Sarcomas
The checkpoint inhibitor prolonged progression-free survival in patients with four subtypes of metastatic or unresectable locally advanced sarcomas.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 24, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lorlatinib: Another First-Line Option for ALK-Positive NSCLC? Lorlatinib: Another First-Line Option for ALK-Positive NSCLC?
First-line lorlatinib significantly prolonged progression-free survival compared with crizotinib in advanced ALK-positive nonsmall cell lung cancer, according to a phase 3 interim analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 24, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCI May'Kill' Major Mammography Trial, Says Advisor NCI May'Kill' Major Mammography Trial, Says Advisor
An advisory group to the National Cancer Institute is reviewing the"feasibility and relevance" of the ongoing TMIST trial that is comparing 3-D to 2-D mammography and is asking if it should continue.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Treatment May Make COVID-19 Less, Not More, Severe Cancer Treatment May Make COVID-19 Less, Not More, Severe
Cancer treatment appears to alter a patient's immune response to COVID-19 to make infection less severe, and not more severe as has been assumed, suggests a small Israeli study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

A Glimmer of Hope for Immunotherapy in SCLC? A Glimmer of Hope for Immunotherapy in SCLC?
While combination immunotherapy did not show a survival benefit after chemoradiotherapy in small cell lung cancer, longer follow-up and biomarker analysis may reveal some gains, suggests trial data.Medscape News UK (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New First-Line Standard of Care for Esophageal Cancer? New First-Line Standard of Care for Esophageal Cancer?
Pembrolizumab plus chemotherapy should be a new standard of care for first-line treatment, say researchers. Patients with squamous cell carcinomas and higher levels of PD-L1 benefited most.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Not All Prostate Cancer Mutations Created Equal for Olaparib Not All Prostate Cancer Mutations Created Equal for Olaparib
While the PARP inhibitor olaparib is the first of its kind to show an overall survival benefit in progressed metastatic prostate cancer, questions remain over its use in men without BRCA1/2 mutations.Medscape News UK (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

A Breath Test to Diagnose Head and Neck Cancer A Breath Test to Diagnose Head and Neck Cancer
Breath analysis for non-invasive diagnosis of early-stage head and neck squamous cell carcinoma appears to be practical and accurate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

HPV-Mediated Head, Neck Cancers Predicted to Rise for Decades HPV-Mediated Head, Neck Cancers Predicted to Rise for Decades
Expect another 30 to 40 years of increasing numbers of HPV-related oropharynx cancers, said an expert.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news